BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
192,632,743
Total 13F shares
183,186,403
Share change
+2,361,113
Total reported value
$12,041,547,200
Put/Call ratio
81%
Price per share
$65.73
Number of holders
536
Value change
+$135,391,046
Number of buys
257
Number of sells
270

Security key

09061G101

Report period

Q4 2024

Institutions

536

Top holders

10

Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
12%
22,623,503
$1,590,206,059 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
10%
19,278,654
$1,355,096,589 30 Sep 2024
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
9.8%
18,867,435
$1,326,192,006 30 Sep 2024
13F
DODGE & COX
13F
Company
7.2%
13,898,318
$976,912,772 30 Sep 2024
13F
Capital Research Global Investors
13F
Company
5.4%
10,494,955
$737,695,395 30 Sep 2024
13F
VIKING GLOBAL INVESTORS LP
13F
Company
5.1%
9,753,293
$685,558,965 30 Sep 2024
13F
STATE STREET CORP
13F
Company
4.6%
8,823,114
$620,176,683 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
2.2%
4,281,482
$300,945,363 30 Sep 2024
13F
NORGES BANK
13F
Company
1.8%
3,533,543
$248,372,737 30 Sep 2024
13F
Elliott Investment Management L.P.
13F
Company
1.8%
3,500,338
$246,038,758 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
3,260,050
$228,632,168 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.5%
2,811,789
$197,640,704 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
1.2%
2,319,989
$163,072,033 30 Sep 2024
13F
Avoro Capital Advisors LLC
13F
Company
1.1%
2,038,015
$143,252,074 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.8%
1,546,167
$108,680,077 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.77%
1,484,358
$104,335,524 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.73%
1,401,628
$98,520,432 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.7%
1,339,721
$94,173,778 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.63%
1,222,895
$85,957,290 30 Sep 2024
13F
Legal & General Group Plc
13F
Company
0.63%
1,208,590
$84,951,734 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.63%
1,204,397
$84,657,065 30 Sep 2024
13F
1832 Asset Management L.P.
13F
Company
0.6%
1,164,391
$81,845,043 30 Sep 2024
13F
Palo Alto Investors LP
13F
Company
0.57%
1,090,056
$76,620,036 30 Sep 2024
13F
DnB Asset Management AS
13F
Company
0.56%
1,074,628
$75,535,602 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.48%
919,616
$64,701,201 30 Sep 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.47%
910,616
$64,007,199 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.47%
899,979
$63,259,496 30 Sep 2024
13F
Neuberger Berman Group LLC
13F
Company
0.47%
897,579
$63,090,829 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.46%
880,453
$61,887,042 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.45%
870,224
$61,168,195 30 Sep 2024
13F
UBS Group AG
13F
Company
0.45%
861,971
$60,587,942 30 Sep 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.44%
852,797
$59,943,101 30 Sep 2024
13F
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
13F
Company
0.38%
727,670
$51,147,924 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.38%
724,188
$50,903,175 30 Sep 2024
13F
Erste Asset Management GmbH
13F
Company
0.36%
689,935
$48,526,971 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.34%
663,555
$46,642,000 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.33%
642,680
$45,173,977 30 Sep 2024
13F
Man Group plc
13F
Company
0.32%
616,078
$43,304,123 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.31%
598,500
$42,068,565 30 Sep 2024
13F
Swiss National Bank
13F
Company
0.29%
563,600
$39,615,444 30 Sep 2024
13F
Holocene Advisors, LP
13F
Company
0.29%
563,476
$39,606,728 30 Sep 2024
13F
AXA S.A.
13F
Company
0.29%
562,664
$39,549,653 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.28%
545,230
$38,324,161 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.28%
543,072
$38,172,532 30 Sep 2024
13F
Aberdeen Group plc
13F
Company
0.27%
527,681
$37,090,697 30 Sep 2024
13F
Employees Retirement System of Texas
13F
Company
0.25%
491,100
$34,519,000 30 Sep 2024
13F
Novo Holdings A/S
13F
Company
0.25%
490,000
$34,442,100 30 Sep 2024
13F
NOMURA ASSET MANAGEMENT CO LTD
13F
Company
0.25%
485,609
$34,133,457 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.25%
485,375
$34,107,301 30 Sep 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.24%
467,298
$32,846,376 30 Sep 2024
13F

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q4 2024

As of 31 Dec 2024, BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by 536 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 183,186,403 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, Capital Research Global Investors, VIKING GLOBAL INVESTORS LP, STATE STREET CORP, AMERIPRISE FINANCIAL INC, NORGES BANK, and Elliott Investment Management L.P.. This page lists 540 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
545
Q4 2024 holders
536
Holder diff
-9
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .